null

SMILES: Cc1cc(Oc2ncnc3occc23)ccc1-c1c(C)n[nH]c(=O)c1C

InChI Key: InChIKey=XSXFCXDSCVELLC-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 285640   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
D(1A) dopamine receptor (Homo sapiens (Human))	BDBM285640 (5-[4-(furo[2,3-d]pyrimidin-4-yloxy)-2-methylphenyl...) Show SMILES Cc1cc(Oc2ncnc3occc23)ccc1-c1c(C)n[nH]c(=O)c1C |(-3.81,-14.36,;-3.81,-15.9,;-5.14,-16.67,;-5.14,-18.21,;-6.48,-18.98,;-6.48,-20.52,;-5.14,-21.29,;-5.14,-22.83,;-6.48,-23.6,;-7.81,-22.83,;-9.27,-23.31,;-10.18,-22.06,;-9.27,-20.82,;-7.81,-21.29,;-3.81,-18.98,;-2.47,-18.21,;-2.47,-16.67,;-1.14,-15.9,;.19,-16.67,;.19,-18.21,;1.53,-15.9,;1.53,-14.36,;.19,-13.59,;.19,-12.05,;-1.14,-14.36,;-2.47,-13.59,)| Show InChI InChI=1S/C19H16N4O3/c1-10-8-13(26-19-15-6-7-25-18(15)20-9-21-19)4-5-14(10)16-11(2)17(24)23-22-12(16)3/h4-9H,1-3H3,(H,23,24)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	30.7	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharmaceuticals					Assay Description D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...				J Med Chem 48: 364-79 (2005) BindingDB Entry DOI: 10.7270/Q2125VZD
					More data for this Ligand-Target Pair
D(1A) dopamine receptor (Homo sapiens (Human))	BDBM285640 (5-[4-(furo[2,3-d]pyrimidin-4-yloxy)-2-methylphenyl...) Show SMILES Cc1cc(Oc2ncnc3occc23)ccc1-c1c(C)n[nH]c(=O)c1C |(-3.81,-14.36,;-3.81,-15.9,;-5.14,-16.67,;-5.14,-18.21,;-6.48,-18.98,;-6.48,-20.52,;-5.14,-21.29,;-5.14,-22.83,;-6.48,-23.6,;-7.81,-22.83,;-9.27,-23.31,;-10.18,-22.06,;-9.27,-20.82,;-7.81,-21.29,;-3.81,-18.98,;-2.47,-18.21,;-2.47,-16.67,;-1.14,-15.9,;.19,-16.67,;.19,-18.21,;1.53,-15.9,;1.53,-14.36,;.19,-13.59,;.19,-12.05,;-1.14,-14.36,;-2.47,-13.59,)| Show InChI InChI=1S/C19H16N4O3/c1-10-8-13(26-19-15-6-7-25-18(15)20-9-21-19)4-5-14(10)16-11(2)17(24)23-22-12(16)3/h4-9H,1-3H3,(H,23,24)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	40.2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharmaceuticals					Assay Description D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...				J Med Chem 48: 364-79 (2005) BindingDB Entry DOI: 10.7270/Q2125VZD
					More data for this Ligand-Target Pair
D(1A) dopamine receptor (Homo sapiens (Human))	BDBM285640 (5-[4-(furo[2,3-d]pyrimidin-4-yloxy)-2-methylphenyl...) Show SMILES Cc1cc(Oc2ncnc3occc23)ccc1-c1c(C)n[nH]c(=O)c1C |(-3.81,-14.36,;-3.81,-15.9,;-5.14,-16.67,;-5.14,-18.21,;-6.48,-18.98,;-6.48,-20.52,;-5.14,-21.29,;-5.14,-22.83,;-6.48,-23.6,;-7.81,-22.83,;-9.27,-23.31,;-10.18,-22.06,;-9.27,-20.82,;-7.81,-21.29,;-3.81,-18.98,;-2.47,-18.21,;-2.47,-16.67,;-1.14,-15.9,;.19,-16.67,;.19,-18.21,;1.53,-15.9,;1.53,-14.36,;.19,-13.59,;.19,-12.05,;-1.14,-14.36,;-2.47,-13.59,)| Show InChI InChI=1S/C19H16N4O3/c1-10-8-13(26-19-15-6-7-25-18(15)20-9-21-19)4-5-14(10)16-11(2)17(24)23-22-12(16)3/h4-9H,1-3H3,(H,23,24)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	44.7	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...				US Patent US10077272 (2018) BindingDB Entry DOI: 10.7270/Q2JH3P6V
					More data for this Ligand-Target Pair
D(1A) dopamine receptor (Homo sapiens (Human))	BDBM285640 (5-[4-(furo[2,3-d]pyrimidin-4-yloxy)-2-methylphenyl...) Show SMILES Cc1cc(Oc2ncnc3occc23)ccc1-c1c(C)n[nH]c(=O)c1C |(-3.81,-14.36,;-3.81,-15.9,;-5.14,-16.67,;-5.14,-18.21,;-6.48,-18.98,;-6.48,-20.52,;-5.14,-21.29,;-5.14,-22.83,;-6.48,-23.6,;-7.81,-22.83,;-9.27,-23.31,;-10.18,-22.06,;-9.27,-20.82,;-7.81,-21.29,;-3.81,-18.98,;-2.47,-18.21,;-2.47,-16.67,;-1.14,-15.9,;.19,-16.67,;.19,-18.21,;1.53,-15.9,;1.53,-14.36,;.19,-13.59,;.19,-12.05,;-1.14,-14.36,;-2.47,-13.59,)| Show InChI InChI=1S/C19H16N4O3/c1-10-8-13(26-19-15-6-7-25-18(15)20-9-21-19)4-5-14(10)16-11(2)17(24)23-22-12(16)3/h4-9H,1-3H3,(H,23,24)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	44.7	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharmaceuticals					Assay Description D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...				J Med Chem 48: 364-79 (2005) BindingDB Entry DOI: 10.7270/Q2125VZD
					More data for this Ligand-Target Pair